Levofloxacin and Tobramycin for Severe Bacterial Keratouveitis

References

• Vajpayee RB, Dada T, Saxena R, et al. Study of the first contact management profile of cases of infectious keratitis: a hospital-based study. Cornea. 2000;9:52–56
   Web of Science ®Google Scholar
• Bourcier T, Thomas F, Borderie V, et al. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol. 2003;87:834–838
   PubMed Web of Science ®Google Scholar
• Gopinathan U, Sharma S, Garg P, et al. Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decade. Indian J Ophthalmol. 2009;57:273–279
   PubMed Web of Science ®Google Scholar
• Saeed A, D'Arcy F, Stack J, et al. Risk factors, microbiological findings, and clinical outcomes in cases of microbial keratitis admitted to a tertiary referral center in Ireland. Cornea. 2009;28:285–292
   PubMed Web of Science ®Google Scholar
• Amescua G, Miller D, Alfonso EC. What is causing the corneal ulcer? Management strategies for unresponsive corneal ulceration. Eye. 2012;26:228–236
   PubMed Web of Science ®Google Scholar
• Leck AK, Thomas PA, Haganet M, et al. Aetiology of suppurative corneal ulcers in Ghana and South India, and epidemiology of fungal keratitis. Br J Ophthalmol. 2002;86:1211–1215
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–516
   PubMed Web of Science ®Google Scholar
• McLeod SD, LaBree LD, Tayyanipour R, et al. The importance of initial management in the treatment of severe infectious corneal ulcers. Ophthalmology. 1995;102:1943–1948
   PubMed Web of Science ®Google Scholar
• Schaefer F, Bruttin O, Zografos L, et al. Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol. 2001;85:842–847
   PubMed Web of Science ®Google Scholar
• Liesegang TJ. Contact lens-related microbial keratitis, part I: epidemiology. Cornea. 1997;16:125–131
   PubMed Web of Science ®Google Scholar
• Matthews TD, Frazer DD, Minassian DC, et al. Risks of keratitis and patterns of use with disposable contact lenses. Arch Ophthalmol. 1992;110:1559–1562
   PubMed Web of Science ®Google Scholar
• Prokosch V, Gatzioufas Z, Thanos S, et al. Microbiological findings and predisposing risk factors in corneal ulcers. Graefes Arch Clin Exp Ophthalmol. 2012;250:369–374
   PubMed Web of Science ®Google Scholar
• Wong T, Ormonde S, Gamble G, et al. Severe infective keratitis leading to hospital admission in New Zealand. Br J Ophthalmol. 2003;87:1103–1108
   PubMed Web of Science ®Google Scholar
• Konda N, Motukupally SR, Garg P, et al. Microbial analyses of contact lens-associated microbial keratitis. Optom Vis Sci. 2014;91:47–53
   PubMed Web of Science ®Google Scholar
• Alexandrakis G, Alfonso CE, Miller D. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology. 2000;107:1497–1502
   PubMed Web of Science ®Google Scholar
• Yildiz EH, Airiani S, Hammersmith KM, et al. Trends in contact lens-related corneal ulcers at a tertiary referral center. Cornea. 2012;31:1097–1102
   PubMed Web of Science ®Google Scholar
• Stapleton F, Carnt N. Contact lens-related microbial keratitis: how have epidemiology and genetics helped us with pathogenesis and prophylaxis. Eye. 2012;26:185–193
   PubMed Web of Science ®Google Scholar
• Butler TK, Spenser NA, Chan CC, et al. Infectious keratitis in older patients: a 4-year review, 1998–2002. Br J Ophthalmol. 2005;89:591–596
   PubMed Web of Science ®Google Scholar
• Kunimoto DY, Sharma S, Garg P, et al. Corneal ulceration in the elderly in Hyderabad, south India. Br J Ophthalmol. 2000;84:54–59
   PubMed Web of Science ®Google Scholar
• Allan BD, Dart JK. Strategies in the management of microbial keratitis. Br J Ophthalmol. 1995;79:777–786
   PubMed Web of Science ®Google Scholar
• Ofloxacin Study Group. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. Ophthalmology. 1997;104:1902–1909
   PubMed Web of Science ®Google Scholar
• Gangopadhyay N, Daniell M, Weih L, et al. Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers. Br J Ophthalmol. 2000;84:378–384
   PubMed Web of Science ®Google Scholar
• Sharma N, Goel M, Bansal S, et al. Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial. Ophthalmology. 2013;120:1173–1178
   PubMed Web of Science ®Google Scholar
• Hanet MS, Jamart J, Chaves AP. Fluoroquinolones or fortified antibiotics for treating bacterial keratitis: systematic review and meta-analysis of comparative studies. Can J Ophthalmol. 2012;47:493–499
   PubMed Web of Science ®Google Scholar
• Khokhar S, Sindhu N, Mirdha BR. Comparison of topical 0.3% ofloxacin to fortified tobramycin-cefazolin in the therapy of bacterial keratitis. Infection. 2000;28:149–152
   PubMed Web of Science ®Google Scholar
• Hurst M, Lamb HM, Scott LJ, et al. Levofloxacin: an updated review of its use in the treatment of bacterial infections. Drugs. 2002;62:2127–2167
   PubMed Web of Science ®Google Scholar
• Kobayakawa S, Tochikubo T, Tsuji A. Penetration of levofloxacin into human aqueous humor. Ophthalmic Res. 2003;35:97–101
   PubMed Web of Science ®Google Scholar
• Colin J, Simonpoli S, Geldsetzer K, et al. Corneal penetration of levofloxacin into the human aqueous humour: a comparison with ciprofloxacin. Acta Ophthalmol Scand. 2003;81:611–613
   PubMedGoogle Scholar
• Healy DP, Holland EJ, Nordlund ML, et al. Concentrations of levofloxacin, ofloxacin, and ciprofloxacin in human corneal stromal tissue and aqueous humor after topical administration. Cornea. 2004;23:255–263
   PubMed Web of Science ®Google Scholar
• Kowalski RP, Dhaliwal DK, Karenchak LM, et al. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol. 2003;136:500–505
   PubMed Web of Science ®Google Scholar
• Kowalski RP, Kowalski TA, Shanks RM, et al. In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection. Cornea. 2013;32:830–834
   PubMed Web of Science ®Google Scholar
• Burgess DS, Hall RG, Hardin TC. In vitro evaluation of the activity of two doses of levofloxacin alone and in combination with other agents against Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 2003;46:131–137
   PubMed Web of Science ®Google Scholar
• Suzuki T, Ohashi Y. Combination effect of antibiotics against bacteria isolated from keratitis using fractional inhibitory concentration index. Cornea. 2013;32:156–160
   Google Scholar
• Hyndiuk RA, Eiferman RA, Caldwell DR, et al. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group. Ophthalmology. 1996;103:1854–1862
   PubMed Web of Science ®Google Scholar
• Shah VM, Tandon R, Satpathy G, et al. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers. Cornea. 2010;29:751–757
   PubMed Web of Science ®Google Scholar
• Snyder RW, Glasser DB. Antibiotic therapy for ocular infection. West J Med. 1994;161:579–584
   PubMedGoogle Scholar
• Constantinou M, Daniell M, Snibson GR, et al. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial. Ophthalmology. 2007;114:1622–1629
   PubMed Web of Science ®Google Scholar
• Prajna NV, George C, Selvaraj S, et al. Bacteriologic and clinical efficacy of ofloxacin 0.3% versus ciprofloxacin 0.3% ophthalmic solutions in the treatment of patients with culture-positive bacterial keratitis. Cornea. 2001;20:175–178
   PubMed Web of Science ®Google Scholar
• Panda A, Ahuja R, Sastry SS. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis. Eye. 1999;13:744–747
   PubMed Web of Science ®Google Scholar
• Parmar P, Salman A, Kalavathy CM, et al. Microbial keratitis at extremes of age. Cornea. 2006;25:153–158
   PubMed Web of Science ®Google Scholar
• van der Meulen IJ, van Rooij J, Nieuwendaal CP, et al. Age-related risk factors, culture outcomes, and prognosis in patients admitted with infectious keratitis to two Dutch tertiary referral centers. Cornea. 2008;27:539–544
   PubMed Web of Science ®Google Scholar
• Srinivasan M, Lalitha P, Mahalakshmi R, et al. Corticosteroids for bacterial corneal ulcers. Br J Ophthalmol. 2009;93:198–202
   PubMed Web of Science ®Google Scholar
• Stern GA, Buttross M. Use of corticosteroids in combination with antimicrobial drugs in the treatment of infectious corneal disease. Ophthalmology. 1991;98:847–853
   PubMed Web of Science ®Google Scholar
• Wilhelmus KR. Indecision about corticosteroids for bacterial keratitis: an evidence-based update. Ophthalmology. 2002;109:835–842
   PubMed Web of Science ®Google Scholar
• Sy A, Srinivasan M, Mascarenhas J, et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Invest Ophthalmol Vis Sci. 2012;53:267–272
   PubMed Web of Science ®Google Scholar
• Blair J, Hodge W, Al-Ghamdi S, et al. Comparison of antibiotic-only and antibiotic-steroid combination treatment in corneal ulcer patients: double-blinded randomized clinical trial. Can J Ophthalmol. 2011;46:40–45
   PubMed Web of Science ®Google Scholar
• Srinivasan M, Mascarenhas J, Rajaraman R, et al. Steroids for Corneal Ulcers Trial Group. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol. 2012;130:143–150
   PubMed Web of Science ®Google Scholar
• Srinivasan M, Mascarenhas J, Rajaraman R, et al. Steroids for Corneal Ulcers Trial Group. The Steroids for Corneal Ulcers Trial (SCUT): Secondary 12-Month Clinical Outcomes of a Randomized Controlled Trial. Am J Ophthalmol. 2014;157:327–333
   PubMed Web of Science ®Google Scholar